Peritoneal dialysis after left ventricular assist device placement.

Area of Science:

• Nephrology
• Cardiology
• Medical Devices

Background:

• Refractory congestive heart failure often necessitates left ventricular assist device (LVAD) implantation.
• Post-LVAD renal failure can arise from cardiorenal syndrome or intrinsic renal disease, potentially requiring renal replacement therapy (RRT).

Observation:

• A unique case of a patient successfully utilizing peritoneal dialysis (PD) for RRT, initiated one year after LVAD implantation for destination therapy (DT).
• The patient maintained successful PD utilization for RRT for an additional year, demonstrating long-term feasibility.

Findings:

• Peritoneal dialysis offers sustained daily ultrafiltration, promoting hemodynamic stability and preserving residual renal function in LVAD patients.
• Potential benefits of PD include a reduced risk of systemic infection compared to other RRT modalities.
• Limitations such as nutritional risks (albumin loss), hyperglycemia, and catheter placement challenges must be considered.

Implications:

• Peritoneal dialysis presents a potentially advantageous RRT option for patients with LVADs requiring renal support.
• Despite limitations, the successful long-term outcome suggests PD should be strongly considered in this patient population.
• Further research into PD's efficacy and safety in LVAD patients is warranted.